Skip to main content
ANTX logo

ANTX

AN2 Therapeutics, Inc.
$4.42 -0.28 (-5.96%) At close · Jul 2
Market Cap
$159.19M
Shares
36,016,161

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 52
Total Value: $74,879,097
Total Shares: 21,894,480

Institutional Ownership Trend

17 quarters

Holder Concentration

Across 52 13F filers · Δ vs Dec 31, 2025
Top Holder
14.4%
Jun 2023 → Mar 2026 · range 11.8% – 42.5%
−2.7 pts
Top 5
49.6%
Jun 2023 → Mar 2026 · range 49.6% – 79.9%
−2.3 pts
Top 10
70.0%
Jun 2023 → Mar 2026 · range 70.0% – 95.5%
−5.4 pts
HHI
665
Jun 2023 → Mar 2026 · range 665 – 2,270
Broadly held−114

Quarterly Activity

vs Dec 31, 2025
New
25
Increased
13
Decreased
9
Sold Out
11
Unchanged
5
Holder count: +14
Institutional value: +373.5%
Shares held: +57.8%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 52 of 52
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1880438 CUSIP 037326105 Visit website Investor relations